Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
NCT05732506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 411
Last updated 2025-04-11
Summary
The aim of the present study is to prospectively evaluate the safety of Edoxaban.
Conditions
- Auricular Fibrillation
Interventions
- DRUG
-
Edoxaban
There are not intervention.
Sponsors & Collaborators
-
Galaxia Empírica
lead NETWORK
Principal Investigators
-
Álvaro Hermida Ameijeiras
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2025-03-31
- Completion
- 2025-04-09
- FDA Drug
- Yes
Countries
- Spain
Study Locations
More Related Trials
-
Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe
NCT02240654 ·Status: COMPLETED
-
A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation
NCT02047565 ·Status: COMPLETED ·Phase: PHASE1
-
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
NCT02943993 ·Status: COMPLETED
-
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
NCT03666650 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
NCT04121767 ·Status: COMPLETED ·Phase: NA
-
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
NCT02942576 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation
NCT03489395 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
NCT04878497 ·Status: UNKNOWN
-
Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
NCT02866175 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
NCT06149533 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment
NCT02182024 ·Status: COMPLETED ·Phase: PHASE1
-
Periprocedural Direct Oral Anticoagulant Management
NCT03182218 ·Status: COMPLETED
-
Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA
NCT01139658 ·Status: COMPLETED
-
Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist
NCT00075985 ·Status: COMPLETED
-
Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
NCT02149303 ·Status: COMPLETED
-
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
NCT00504556 ·Status: COMPLETED ·Phase: PHASE2
-
DOAC ADRs Retrospective Study on Genetic Variations
NCT04580589 ·Status: COMPLETED
-
Edoxaban Management in Diagnostic and Therapeutic Procedures
NCT02950168 ·Status: COMPLETED
-
LEAVE Safe With DOACs
NCT04068727 ·Status: COMPLETED ·Phase: NA
-
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
NCT03395639 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Expansion of Comparative Effectiveness of Anticoagulants
NCT02081807 ·Status: COMPLETED
-
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
NCT03280368 ·Status: COMPLETED
-
EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation
NCT02561897 ·Status: TERMINATED ·Phase: PHASE4
-
Patient Convenience Study
NCT02597920 ·Status: COMPLETED
-
Resolution of Thrombi in Left Atrial Appendage With Edoxaban
NCT03840291 ·Status: COMPLETED ·Phase: PHASE4